Relative change rate of neutrophil-to-albumin ratio (ΔNAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer
Yujie Zhao, Yuxiang Deng, Weicai Chen, Meiyu Liu, Zhaoming Peng, Yajie Liu, Lei Zhang · 2026
Read Relative change rate of neutrophil-to-albumin ratio (ΔNAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer by Yujie Zhao, Yuxiang Deng, Weicai Chen, Meiyu Liu, Zhaoming Peng, Yajie Liu, Lei Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13657730.txt.
Description
Yujie Zhao and co-authors test a moving blood marker in 2026 for predicting how breast cancer answers early chemotherapy. Chemotherapy before surgery can clear cancer from the armpit lymph nodes, and that result guides surgery and outlook.
The team tracked the ratio of neutrophils to albumin, two routine blood values that reflect inflammation and nutrition. They used its relative change across the treatment course, not just the starting value. In 169 patients with node positive, locally advanced disease, a drop beyond a set cutoff went with a far higher rate of cleared nodes. The change held up as an independent predictor alongside hormone and growth factor status.
Catalog record
| CREATOR | Yujie Zhao, Yuxiang Deng, Weicai Chen, Meiyu Liu, Zhaoming Peng, Yajie Liu, Lei Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |